Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia

Summary

RATIONALE: Monoclonal antibodies can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells. PURPOSE: Phase I trial to study the effectiveness of monoclonal antibody therapy in treating patients who have chronic lymphocytic leukemia.

Timeline

Start

1996-03

Primary completion

—

Completion

—

Drugs

Indications